Molecular Awards

  It's easy to feel powerless against cancer, but a new study has identified several ways that we can reduce the odds of it occurring. According to new analysis from the World Health Organization (WHO), more than a third of all cancer cases globally are preventable. Lung, stomach, and cervical cancers make up nearly half of those cases. This means that millions of deadly cancers every year could be prevented through medical intervention, behavior changes, reducing occupational risks, or tackling environmental pollutants. "Addressing these preventable causes represents one of the most powerful opportunities to reduce the global cancer burden," says Isabelle Soerjomataram, medical epidemiologist at WHO and senior author of the analysis. Website Link: molecularbiologist.org/ Contact Mail ID : support@molecularbiologist.org Nomination Link  : https://molecularbiologist.org/award-nomination/?ecategory=Awards&rcategory=Awardee #LifestyleFactors...

  In the realm of organ transplantation, the integration of pharmacogenomics into clinical practice has emerged as a transformative approach that holds the potential to significantly enhance patient outcomes. The recent literature, particularly a review by researchers K.D. Belfield, E.A. Cohen, and G. Girone, sheds light on the profound implications of pharmacogenomics in transplantation. This exciting field explores how an individual’s genetic makeup can influence their response to medications, thereby revolutionizing personalized medicine in organ transplant recipients. At the heart of pharmacogenomics is the interaction between genetics and drug metabolism. Each patient possesses a unique genetic profile that impacts how their body processes medications. In the context of transplantation, this means that the standard immunosuppressive therapies often prescribed may not be equally effective for every individual. By understanding these genetic variances, clinicians can tailor medi...